Cydni Williams

Dr. Cydni Williams

Department of Pediatrics, Division of Critical Care, Pediatric Critical Care and Neurotrauma Recovery Program, Oregon Health & Science University, Portland, OR, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Pediatric Neurology
Verified
Journal Article
Closed access
Cydni WilliamsCydni Williams
Cydni Williams
JPJuan Piantino
Juan Piantino
CMCynthia McEvoy
Cynthia McEvoy
NFNora Fino
Nora Fino
CECarl O. Eriksson
Carl O. Eriksson

14 April 2010 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
RMRené Y. McNall‐Knapp
René Y. McNall‐Knapp
Cydni WilliamsCydni Williams
Cydni Williams
ERElaine N. Reeves
Elaine N. Reeves
RHRichard L. Heideman
Richard L. Heideman
WMWilliam H. Meyer
William H. Meyer

18 September 2018 in Pediatric Neurology
Verified
Journal Article
Closed access
JDJonathan N. Dodd
Jonathan N. Dodd
THTrevor A. Hall
Trevor A. Hall
KGKristin Guilliams
Kristin Guilliams
RGRejean M Guerriero
Rejean M Guerriero
AWAmanda Wagner
Amanda Wagner
JPJuan Piantino
Juan Piantino

1 December 2019 in Hospital Pediatrics
Verified
Journal Article
Closed access
PDF file
Cydni WilliamsCydni Williams
Cydni Williams
CECarl O. Eriksson
Carl O. Eriksson
AKAileen Kirby
Aileen Kirby
JPJuan A. Piantino
Juan A. Piantino
THTrevor A. Hall
Trevor A. Hall
CMCindy T. McEvoy
Cindy T. McEvoy
OBJECTIVES: Pediatric neurocritical care (PNCC) outcomes research is scarce. We aimed to expand knowledge about outcomes in PNCC by evaluating death and changes in Functional Status Scale (FSS) from baseline among PNCC diagnoses. METHODS: We conducted a 2-year observational study of children aged 0 to 18 years admitted to the ICU with a primary neurologic diagnosis (N = 325). Primary outcomes were death and change in FSS from preadmission baseline to discharge. New disability was defined as an FSS change of ≥1 from baseline, and severe disability was defined as an FSS change of ≥3. Categorical results are reported as relative risk (RR) with 95% confidence interval (CI). RESULTS: Thirty (9%) patients died. New disability (n = 103; 35%) and severe disability (n = 37; 13%) were common in PNCC survivors. New disability (range 14%–54%) and severe disability (range 3%–33%) outcomes varied significantly among primary diagnoses (lowest in status epilepticus; highest in infectious and/or inflammatory and stroke cohorts). Disability occurred in all FSS domains: mental status (15%), sensory (52%), communication (38%), motor (48%), feeding (40%), and respiratory (12%). Most (64%) patients with severe disability had changes in ≥3 domains. Requiring critical care interventions (RR 2.1; 95% CI 1.5–3.1) and having seizures (RR 1.5; 95% CI 1.1–2.0) during hospitalization were associated with new disability. CONCLUSIONS: PNCC patients have high rates of death and new disability at discharge, varying significantly between PNCC diagnoses. Multiple domains of disability are affected, underscoring the ongoing multidisciplinary health care needs of survivors. Our study quantified hospital outcomes of PNCC patients that can be used to advance future research in this vulnerable population.

22 March 2022 in Hospital Pediatrics
Verified
Journal Article
Open access
PDF file
Cydni WilliamsCydni Williams
Cydni Williams
THTrevor A. Hall
Trevor A. Hall
CFConall Francoeur
Conall Francoeur
JKJonathan Kurz
Jonathan Kurz
LRLindsey Rasmussen
Lindsey Rasmussen
O(ON BEHALF OF THE PEDIATRIC NEUROCRITICAL CARE RESEARCH GROUP (PNCRG).
ON BEHALF OF THE PEDIATRIC NEUROCRITICAL CARE RESEARCH GROUP (PNCRG).
Survivors of the PICU face long-term morbidities across health domains. In this study, we detail active PICU follow-up programs (PFUPs) and identify perceptions and barriers about development and maintenance of PFUPs. A web link to an adaptive survey was distributed through organizational listservs. Descriptive statistics characterized the sample and details of existing PFUPs. Likert responses regarding benefits and barriers were summarized. One hundred eleven respondents represented 60 institutions located in the United States (n = 55), Canada (n = 3), Australia (n = 1), and the United Kingdom (n = 1). Details for 17 active programs were provided. Five programs included broad PICU populations, while the majority were neurocritical care (53%) focused. Despite strong agreement on the need to assess and treat morbidity across multiple health domains, 29% were physician only programs, and considerable variation existed in services provided by programs across settings. More than 80% of all respondents agreed PFUPs provide direct benefits and are essential to advancing knowledge on long-term PICU outcomes. Respondents identified “lack of support” as the most important barrier, particularly funding for providers and staff, and lack of clinical space, though successful programs overcome this challenge using a variety of funding resources. Few systematic multidisciplinary PFUPs exist despite strong agreement about importance of this care and direct benefit to patients and families. We recommend stakeholders use our description of successful programs as a framework to develop multidisciplinary models to elevate continuity across inpatient and outpatient settings, improve patient care, and foster collaboration to advance knowledge.

19 September 2017 in Children
Verified
Journal Article
Open access
PDF file
Cydni WilliamsCydni Williams
Cydni Williams
AKAileen Kirby
Aileen Kirby
JPJuan Piantino
Juan Piantino
Pediatric Neurocritical Care diagnoses account for a large proportion of intensive care admissions. Critical care survivors suffer high rates of long-term morbidity, including physical disability, cognitive impairment, and psychosocial dysfunction. To address these morbidities in Pediatric Neurocritical Care survivors, collaboration between Pediatric Neurology and Pediatric Critical Care created a multidisciplinary follow-up clinic providing specialized evaluations after discharge. Clinic referrals apply to all Pediatric Neurocritical Care patients regardless of admission severity of illness. Here, we report an initial case series, which revealed a population that is heterogenous in age, ranging from 1 month to 18 years, and in diagnoses. Traumatic brain injuries of varying severity as well as neuroinfectious and inflammatory diseases accounted for the majority of referrals. Most patients (87%) seen in the clinic had morbidities identified, requiring ongoing evaluation and expansion of the clinic. Cognitive and psychological disturbance were seen in over half of patients at the initial clinic follow-up. Sleep disturbances, daytime fatigue, headache or chronic pain, and vision or hearing concerns were also common at initial follow-up. Data from this initial population of clinic patients reiterates the need for specialized follow-up care, but also highlights the difficulties related to providing this comprehensive care and evaluating interventions to improve outcomes.